Patent Assignment
Reel/Frame 061086/0886
Merger
Recorded: 2022-03-23
Pages: 9
Assignor
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2017-12-29
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Lipid Containing Formulations
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 17, 2021
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; AKINC, AKIN; NAIR, JAYAPRAKASH K.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 055626/0896 →
Assignment of Assignor's Interest
Mar 19, 2021
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 055648/0491 →
Change of Name
Mar 22, 2022
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 059337/0845 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →